HYPOFRACTIONATED EXTERNAL BEAM RADIATION WITH BEVACIZUMAB FOR THE TREATMENT OF RECURRENT HIGH GRADE GLIOMA - REPORT OF TWO CASES

被引：0
|
作者：
Gilheeney, S. W. [1 ]
Wolden, S. [1 ]
Dunkel, I. J. [1 ]
Khakoo, Y. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
NEURO-ONCOLOGY | 2010年 / 12卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：II74 / II74
页数：1
相关论文
共 50 条
  • [21] Re-irradiation and bevacizumab in recurrent high-grade glioma: an effective treatment option
    Flieger, Maya
    Ganswindt, Ute
    Schwarz, Silke Birgit
    Kreth, Friedrich-Wilhelm
    Tonn, Joerg-Christian
    la Fougere, Christian
    Ertl, Lorenz
    Linn, Jennifer
    Herrlinger, Ulrich
    Belka, Claus
    Niyazi, Maximilian
    JOURNAL OF NEURO-ONCOLOGY, 2014, 117 (02) : 337 - 345
  • [22] Re-irradiation and bevacizumab in recurrent high-grade glioma: an effective treatment option
    Maya Flieger
    Ute Ganswindt
    Silke Birgit Schwarz
    Friedrich-Wilhelm Kreth
    Jörg-Christian Tonn
    Christian la Fougère
    Lorenz Ertl
    Jennifer Linn
    Ulrich Herrlinger
    Claus Belka
    Maximilian Niyazi
    Journal of Neuro-Oncology, 2014, 117 : 337 - 345
  • [23] Combining Fractionated Stereotactic Radiation Therapy and Bevacizumab for Recurrent High-Grade Glioma: Outcomes Analysis
    Siglin, J. J.
    Champ, C. E.
    Zhang, I.
    Dan, T.
    Glass, J.
    Evans, J. J.
    Andrews, D. W.
    Werner-Wasik, M.
    Shi, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S159 - S159
  • [24] The efficacy and safety of CyberKnife combined with bevacizumab and temozolomide in the treatment of recurrent high-grade glioma
    Jingbo, K.
    ANNALS OF ONCOLOGY, 2020, 31 : S402 - S402
  • [25] Patterns of Failure in Patients With Recurrent High-Grade Glioma Treated With Hypofractionated Stereotactic Re-rradiation, Pembrolizumab, and Bevacizumab
    Padmanabhan, R.
    Zhang, G. G.
    Oliver, D. E.
    Graham, J.
    Grass, D.
    Sahebjam, S.
    Yu, H. H. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E596 - E597
  • [26] Re-Irradiation with Bevacizumab in recurrent high-grade Glioma
    Niyazi, M.
    Ganswindt, U.
    Schwarz, S. B.
    Schnell, O.
    Belka, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 75 - 75
  • [27] Bevacizumab reduces toxicity of reirradiation in recurrent high-grade glioma
    Fleischmann, Daniel Felix
    Jenn, Johanna
    Corradini, Stefanie
    Ruf, Viktoria
    Herms, Jochen
    Forbrig, Robert
    Unterrainer, Marcus
    Thon, Niklas
    Kreth, Friedrich Wilhelm
    Belka, Claus
    Niyazi, Maximilian
    RADIOTHERAPY AND ONCOLOGY, 2019, 138 : 99 - 105
  • [28] An Observational Study of the First Experience with Bevacizumab for the Treatment of Patients with Recurrent High-Grade Glioma in Two Belgian University Hospitals
    Huylebrouck, M.
    Lv, S.
    Duerinck, J.
    Van Binst, A.
    Salmon, I.
    De Greve, J.
    DeWitte, O.
    Luce, S.
    Michotte, A.
    D'Haens, J.
    Neyns, B.
    JOURNAL OF ONCOLOGY, 2012, 2012
  • [29] A PHASE II STUDY OF THE EFFICACY OF HYPOFRACTIONATED RADIATION THERAPY WITH BEVACIZUMAB AND TEMOZOLOMIDE FOLLOWED BY MAINTENANCE TEMOZOLOMIDE AND BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMAS
    Dixit, Karan
    Kumthekar, Priya
    Kruser, Timothy
    Sachdev, Sean
    Kalapurakal, John A.
    Gondi, Vinai
    Grimm, Sean
    Nicholas, Martin
    Lukas, Rimas V.
    Chmura, Steven J.
    Mehta, Minesh P.
    Raizer, Jeffrey
    NEURO-ONCOLOGY, 2017, 19 : 19 - 20
  • [30] Occurrence of high-grade glioma in Noonan syndrome: Report of two cases
    El-Ayadi, Moatasem
    Ansari, Marc
    Kuehnoel, Caspar D.
    Bendel, Anne
    Sturm, Dominik
    Pietsch, Torsten
    Kramm, Christof M.
    von Bueren, Andre O.
    PEDIATRIC BLOOD & CANCER, 2019, 66 (05)
12345